APA (7th ed.) Citation

MJ, v. D., TJJ, R., S, v. d. V., MAE, R., BA, v. O., J, B., . . . R, v. W. (2024). Metabolic blood profile and response to treatment with the pyruvate kinase activator mitapivat in patients with sickle cell disease. HemaSphere, 8(6), e109. https://doi.org/10.1002/hem3.109

Chicago Style (17th ed.) Citation

MJ, van Dijk, et al. "Metabolic Blood Profile and Response to Treatment with the Pyruvate Kinase Activator Mitapivat in Patients with Sickle Cell Disease." HemaSphere 8, no. 6 (2024): e109. https://doi.org/10.1002/hem3.109.

MLA (9th ed.) Citation

MJ, van Dijk, et al. "Metabolic Blood Profile and Response to Treatment with the Pyruvate Kinase Activator Mitapivat in Patients with Sickle Cell Disease." HemaSphere, vol. 8, no. 6, 2024, p. e109, https://doi.org/10.1002/hem3.109.